Financhill
Back

Aurinia Pharmaceuticals Vs. Novo Nordisk AS Industry Stock Comparison

Buy
58

AUPH
Aurinia Pharmaceuticals

Last Price:
$8.08
Seasonality Move:
13.93%
Sell
25

NVO
Novo Nordisk AS

Last Price:
$86.31
Seasonality Move:
6.68%
Buy
58
Aurinia Pharmaceuticals (AUPH) is a Buy

Is Aurinia Pharmaceuticals a Buy, Sell or Hold?

  • The current Aurinia Pharmaceuticals [AUPH] share price is $8.34. The Score for AUPH is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • AUPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.64. The Score for NVO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AUPH Stock Price Chart

What is Aurinia Pharmaceuticals's stock price today?

  • The Aurinia Pharmaceuticals share price today is $8.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUPH is experiencing slight selling pressure.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

AUPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 39.04 Sell
Chaikin Money Flow: -636566 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.61 - 9.59) Sell
Bollinger Bands (100): (6.78 - 8.78) Buy

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.06 Sell
Relative Strength Index (14 RSI): 31.71 Sell
Chaikin Money Flow: 6521757 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.72 - 109.1) Sell
Bollinger Bands (100): (99.51 - 129.55) Sell

AUPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.73 Sell
20-day SMA: 9.15 Sell
50-day SMA: 8.61 Sell
200-day SMA: 6.57 Buy
8-day EMA: 8.64 Sell
20-day EMA: 8.85 Sell
50-day EMA: 8.55 Sell
200-day EMA: 7.42 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 86.04 Sell
20-day SMA: 94.95 Sell
50-day SMA: 102.54 Sell
200-day SMA: 123.74 Sell
8-day EMA: 86.81 Sell
20-day EMA: 92.64 Sell
50-day EMA: 101.62 Sell
200-day EMA: 114.8 Sell

Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.29 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.54 per share.

Aurinia Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):